DE69426844D1 - Halbfeste Arzneimittel sowie Verfahren zu deren Herstellung - Google Patents

Halbfeste Arzneimittel sowie Verfahren zu deren Herstellung

Info

Publication number
DE69426844D1
DE69426844D1 DE69426844T DE69426844T DE69426844D1 DE 69426844 D1 DE69426844 D1 DE 69426844D1 DE 69426844 T DE69426844 T DE 69426844T DE 69426844 T DE69426844 T DE 69426844T DE 69426844 D1 DE69426844 D1 DE 69426844D1
Authority
DE
Germany
Prior art keywords
semi
manufacture
processes
bioactive substance
solid drugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69426844T
Other languages
English (en)
Other versions
DE69426844T2 (de
Inventor
Masao Ikeda
Tomoki Tatefuji
Hiroshi Yamauchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hayashibara Seibutsu Kagaku Kenkyujo KK
Original Assignee
Hayashibara Seibutsu Kagaku Kenkyujo KK
Hayashibara Biochemical Laboratories Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hayashibara Seibutsu Kagaku Kenkyujo KK, Hayashibara Biochemical Laboratories Co Ltd filed Critical Hayashibara Seibutsu Kagaku Kenkyujo KK
Application granted granted Critical
Publication of DE69426844D1 publication Critical patent/DE69426844D1/de
Publication of DE69426844T2 publication Critical patent/DE69426844T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/15—Suppositories
DE69426844T 1993-06-28 1994-06-27 Halbfeste Arzneimittel sowie Verfahren zu deren Herstellung Expired - Fee Related DE69426844T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5178614A JPH0776527A (ja) 1993-06-28 1993-06-28 半固形製剤とその製造方法

Publications (2)

Publication Number Publication Date
DE69426844D1 true DE69426844D1 (de) 2001-04-19
DE69426844T2 DE69426844T2 (de) 2001-08-23

Family

ID=16051528

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69426844T Expired - Fee Related DE69426844T2 (de) 1993-06-28 1994-06-27 Halbfeste Arzneimittel sowie Verfahren zu deren Herstellung

Country Status (13)

Country Link
US (1) US5489577A (de)
EP (1) EP0630651B1 (de)
JP (1) JPH0776527A (de)
KR (1) KR100314820B1 (de)
AT (1) ATE199646T1 (de)
AU (1) AU685111B2 (de)
CA (1) CA2126932A1 (de)
DE (1) DE69426844T2 (de)
DK (1) DK0630651T3 (de)
FI (1) FI943103A (de)
NZ (1) NZ260867A (de)
PT (1) PT630651E (de)
TW (1) TW496744B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE215382T1 (de) * 1994-12-29 2002-04-15 Mochida Pharm Co Ltd Ulinastatin enthaltende zäpfchen
JP2001064181A (ja) * 1999-08-27 2001-03-13 Otsuka Pharmaceut Co Ltd 免疫賦活組成物
JP4866519B2 (ja) * 2001-09-21 2012-02-01 天藤製薬株式会社 坐剤の製造法
JP4866518B2 (ja) * 2001-09-21 2012-02-01 天藤製薬株式会社 坐剤の製造法
NZ523100A (en) * 2002-12-10 2005-02-25 Fonterra Co Operative Group A process for producing a carbohydrate composition
DE102004022928A1 (de) * 2004-05-10 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulver enthaltend neuartige Oligosacharidgemische und Verfahren zu deren Herstellung
DE102004022926A1 (de) * 2004-05-10 2005-12-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Sprühgetrocknete Pulver enthaltend zumindest ein 1,4 O-verknüpftes Saccharose-Derivat und Verfahren zu deren Herstellung
US7727962B2 (en) 2004-05-10 2010-06-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder comprising new compositions of oligosaccharides and methods for their preparation
US7723306B2 (en) 2004-05-10 2010-05-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation
US7611709B2 (en) 2004-05-10 2009-11-03 Boehringer Ingelheim Pharma Gmbh And Co. Kg 1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives
DE102004022927A1 (de) * 2004-05-10 2005-12-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg 1,4 O-verknüpfte Saccharose-Derivate zur Stabilisierung von Antikörpern oder Antikörper-Derivaten
DE102006053375A1 (de) * 2006-11-10 2008-05-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Mischung von Pulvern

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
EP0080879B1 (de) * 1981-11-28 1986-10-01 Sunstar Kabushiki Kaisha Stabilisiertes Interferon enthaltende pharmazeutische Zusammensetzung
US4447355A (en) * 1982-04-07 1984-05-08 Asahi Kasei Kogyo Kabushiki Kaisha Method for stabilizing a tumor necrosis factor and a stable aqueous solution or powder containing the same
JPS5921613A (ja) * 1982-07-28 1984-02-03 Takeda Chem Ind Ltd 直腸投与製剤
US4659696A (en) * 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
US4650665A (en) * 1985-02-08 1987-03-17 Ethicon, Inc. Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
US4593038A (en) * 1985-04-03 1986-06-03 Burzynski Stanislaw R Topical use of 3-phenylacetylamino-2,6-piperidinedione for treatment of skin wrinkles and hyperpigmentation
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
US4870059A (en) * 1985-11-27 1989-09-26 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Dehydration of hydrous matter with anhydrous maltose
US4851220A (en) * 1986-11-26 1989-07-25 Schering Corporation Stable oleaginous gel
ES2077948T3 (es) * 1987-03-06 1995-12-01 Kao Corp Preparacion para el cuidado externo de la piel.
HU203204B (en) * 1987-09-15 1991-06-28 Sandoz Ag Process for producing suppository containing calcitonin and taurocholic acid
US5266310A (en) * 1987-09-17 1993-11-30 Boehringer Ingelheim International Gmbh Stabilization of therapeutically active proteins in pharmaceutical preparations
DE3731255A1 (de) * 1987-09-17 1989-04-06 Boehringer Ingelheim Int Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen
US5215743A (en) * 1988-04-13 1993-06-01 Maninder Singh Tumor necrosis factor formulations
US5011824A (en) * 1988-11-16 1991-04-30 Kyowa Hakko Kogyo Co., Ltd. Rectal motilin preparation
EP0399432B1 (de) * 1989-05-25 1994-06-22 Takeda Chemical Industries, Ltd. Transdermales therapeutisches Mittel
JP2945993B2 (ja) * 1989-12-05 1999-09-06 武田薬品工業株式会社 外用剤
WO1991013601A1 (en) * 1990-03-15 1991-09-19 Rhône-Poulenc Rorer International (Holdings) Inc. Calcitonin suppository formulations
US5194261A (en) * 1990-11-27 1993-03-16 Virgil Pichierri Diaper rash treatment
EP0533938A4 (en) * 1991-02-19 1993-06-16 Tsumura & Co. Composition for rectal administration of difficultly absorbable peptide
IT1244500B (it) * 1991-03-21 1994-07-15 Pulitzer Italiana Impiego di sali minerali di trometamina in composizioni farmaceutiche a base di calcitonina somministrabili per via rettale in terapia umana
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels

Also Published As

Publication number Publication date
NZ260867A (en) 1996-01-26
EP0630651A3 (de) 1996-11-06
DE69426844T2 (de) 2001-08-23
PT630651E (pt) 2001-06-29
KR950000168A (ko) 1995-01-03
TW496744B (en) 2002-08-01
JPH0776527A (ja) 1995-03-20
US5489577A (en) 1996-02-06
DK0630651T3 (da) 2001-04-17
EP0630651A2 (de) 1994-12-28
AU685111B2 (en) 1998-01-15
AU6601994A (en) 1995-01-05
CA2126932A1 (en) 1994-12-29
FI943103A (fi) 1994-12-29
FI943103A0 (fi) 1994-06-28
ATE199646T1 (de) 2001-03-15
EP0630651B1 (de) 2001-03-14
KR100314820B1 (ko) 2002-06-20

Similar Documents

Publication Publication Date Title
NL990012I2 (nl) Geneesmiddelen die salmeterol en fluticason bevatten.
ATE74513T1 (de) Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen.
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
DE3688114D1 (de) Inklusionskomplexe von 7-isopropoxy-isoflavon mit cyclodextrinen, verfahren zu deren herstellung und diese inklusionskomplexe enthaltende pharmazeutische praeparate.
BR9809328A (pt) Processo para preparação de formas sólidas de medicamentos empregáveis peroralmente com desprendimento controlado de substância ativa
UA26343C2 (uk) Спосіб одержаhhя коhсервоваhого, що містить протеїh людиhи, лікарського засобу для іh'єкційhого або іhфузійhого введеhhя
DE69426844D1 (de) Halbfeste Arzneimittel sowie Verfahren zu deren Herstellung
EP0221041A3 (de) Benzimidazolderivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
GB2139892B (en) Solid pharmaceutical preparation containing nifedipine
DZ1078A1 (fr) Formulation pharmaceutiques de substance labiles aux acides pour administration orale.
HUP0003583A2 (hu) Ibuprofen tartalmú gyógyászati szerek
DE69025920D1 (de) Glykosaminoglykan-modifiertes Protein, Verfahren zu dessen Herstellung und pharmazeutische Zubereitungen, die es enthalten
EP1161956A4 (de) Medikamentenzusammensetzung
DE3783356D1 (de) Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
DE69002718D1 (de) Medikamente.
AU1935788A (en) A process for producing an administration and/or dosage form for medically active ingredients of drugs
DE3787477D1 (de) Nasal applizierbares Arzneimittel, Verfahren zu seiner Herstellung und seine Verwendung.
ATE110723T1 (de) Verbindungen mit magensäureinhibitorwirkung und verfahren zur herstellung.
EP0271151A3 (de) Azumolen-Dosisformen
DK0559682T3 (da) Topisk præparat
DK649487D0 (da) Praeparat til afgivelse af et topisk laegemiddel
JPS5762221A (en) Embrocation for external use
DE69211743D1 (de) Aureobasidin enthaltendes Arzneimittel
JPS6438027A (en) Remedy for cancer
TH5133A (th) สารผสมทางเภสัชกรรม

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee